Cart
sales@molnova.com
PDE10-IN-1
CAS No. 1516896-09-5
PDE10-IN-1( —— )
Catalog No. M20167 CAS No. 1516896-09-5
PDE10-IN-1 is PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1 for treating CNS and metabolic disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 111 | In Stock |
|
| 10MG | 159 | In Stock |
|
| 25MG | 271 | In Stock |
|
| 50MG | 372 | In Stock |
|
| 100MG | 481 | In Stock |
|
| 200MG | 649 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePDE10-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPDE10-IN-1 is PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1 for treating CNS and metabolic disorders.
-
DescriptionPDE10-IN-1 is PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1 for treating CNS and metabolic disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE10
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1516896-09-5
-
Formula Weight350.42
-
Molecular FormulaC23H18N4
-
Purity>98% (HPLC)
-
SolubilityDMSO:2 mg/mL?(5.41 mM)
-
SMILESCc1c(nc2c3cccnc3ccn12)[C@@H]1C[C@H]1c1nc2c(C)ncc(C)n2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Campbell John Emmerson et al. Preparation of heteroaryl compounds as PDE-10 inhibitors for treating CNS and metabolic disorders. Patent WO 2013192273 A1 20131227.
molnova catalog
related products
-
Siguazodan
Siguazodan is an effective, selective, orally active phosphodiesterase III ((PDE-III)) inhibitor with an IC50 of 117 nM.
-
Robustine
Robustine is a natural product, exhibits inhibitory potency against human phosphodiesterase 5 (hPDE5A) in vitro.
-
Darutigenol
Darutigenol has obvious antithrombotic effect, its mechanism may be related to inhibition of platelet aggregation and adhesion.
